HB 2400 Health insurance; use of drug pricing benchmark value.
Christopher T. Head | all patrons    ...    notes
| add to my profiles

Summary as introduced:

Drug pricing benchmark value. Requires health insurers and other carriers to utilize the same drug pricing benchmark value to reimburse providers, to charge the sponsor of a health plan, and to develop premiums for a health benefit plan. The measure defines a drug pricing benchmark value as the base price of a prescription drug from which the carrier may deviate for reimbursement purposes.

Full text:
01/18/17  House: Presented and ordered printed 17102859D  pdf | impact statement

01/18/17  House: Presented and ordered printed 17102859D
01/18/17  House: Referred to Committee on Commerce and Labor
01/31/17  House: Tabled in Commerce and Labor by voice vote